- Home
- IPGP vs SLNO Comparison
IPGP vs SLNO Comparison
Compare IPGP & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPGP
- SLNO
- Stock Information
- Founded
- IPGP 1990
- SLNO 1999
- Country
- IPGP United States
- SLNO United States
- Employees
- IPGP N/A
- SLNO N/A
- Industry
- IPGP Semiconductors
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IPGP Technology
- SLNO Health Care
- Exchange
- IPGP Nasdaq
- SLNO Nasdaq
- Market Cap
- IPGP 3.3B
- SLNO 3.2B
- IPO Year
- IPGP 2006
- SLNO 2014
- Fundamental
- Price
- IPGP $60.15
- SLNO $76.78
- Analyst Decision
- IPGP Buy
- SLNO Strong Buy
- Analyst Count
- IPGP 7
- SLNO 9
- Target Price
- IPGP $72.75
- SLNO $103.33
- AVG Volume (30 Days)
- IPGP 350.5K
- SLNO 955.8K
- Earning Date
- IPGP 05-06-2025
- SLNO 05-07-2025
- Dividend Yield
- IPGP N/A
- SLNO N/A
- EPS Growth
- IPGP N/A
- SLNO N/A
- EPS
- IPGP N/A
- SLNO N/A
- Revenue
- IPGP $952,918,000.00
- SLNO N/A
- Revenue This Year
- IPGP $2.05
- SLNO N/A
- Revenue Next Year
- IPGP $7.00
- SLNO N/A
- P/E Ratio
- IPGP N/A
- SLNO N/A
- Revenue Growth
- IPGP N/A
- SLNO N/A
- 52 Week Low
- IPGP $48.59
- SLNO $36.93
- 52 Week High
- IPGP $92.21
- SLNO $80.91
- Technical
- Relative Strength Index (RSI)
- IPGP 53.02
- SLNO 65.28
- Support Level
- IPGP $51.77
- SLNO $72.23
- Resistance Level
- IPGP $64.58
- SLNO $80.99
- Average True Range (ATR)
- IPGP 2.49
- SLNO 3.06
- MACD
- IPGP 0.44
- SLNO -0.37
- Stochastic Oscillator
- IPGP 65.42
- SLNO 64.59
About IPGP IPG Photonics Corporation
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from China and also has its presence in North America, Japan, Germany, and other markets.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.